Press Releases

Platform shows promise in facilitating brain-machine communication and providing pain relief for patients (MINNEAPOLIS, Minn.) July 11, 2023 – Fasikl, a Minnesota-based neuro-AI company, is developing AI-supported neural technologies with the mission of making a profound difference in the wellbeing of patients’ lives. Building on a decade of intensive research, the company has developed an…

(MINNEAPOLIS, Minn.) July 12, 2023 – The U.S. Food and Drug Administration has granted “breakthrough device designation” to two products developed by med-tech startup Fasikl.

(MINNEAPOLIS, Minn.) March 3, 2023 – Fasikl has closed a $10 million Series A equity investment to advance its AI-driven therapeutic technologies. The funding will support continued research and development and a pivotal clinical trial to pursue FDA clearance.

(MINNEAPOLIS, Minn.) November 1, 2021 – Fasikl has closed a $5 million Pre- Series A equity investment to accelerate its R&D in AI-driven therapeutic technologies. The funding will support continued research and development and launch a pilot clinical trial to establish a regulatory pathway for AI-based therapeutics.